{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:03:33Z","timestamp":1792821813632,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI144181-01"],"award-info":[{"award-number":["U19 AI144181-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.mucimm.2024.06.012","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T20:58:24Z","timestamp":1720040304000},"page":"1005-1018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in na\u00efve mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Taylor B.","family":"Poston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Grace","family":"Polson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakash","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacy S.","family":"Yount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Jaras Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan K.","family":"Trim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Beagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilu","family":"Goonetilleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Darville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2024.06.012_b0005","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mucimm.2024.06.012_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AOG.0b013e31825a6bc9","article-title":"Subclinical pelvic inflammatory disease and infertility","volume":"120","author":"Wiesenfeld","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0015","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm. Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.mucimm.2024.06.012_b0020","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1086\/652399","article-title":"Protective immunity to chlamydial genital infection: evidence from animal studies","volume":"201","author":"Rank","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.mucimm.2024.06.012_b0025","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/652400","article-title":"Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies","volume":"201","author":"Batteiger","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.06.012_b0030","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/iai.56.8.2023-2027.1988","article-title":"Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection","volume":"56","author":"Byrne","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0035","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/iai.63.12.4661-4668.1995","article-title":"Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection","volume":"63","author":"Morrison","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0040","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.4049\/jimmunol.177.11.7974","article-title":"Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa","volume":"177","author":"Roan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0045","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.4049\/jimmunol.153.11.5183","article-title":"Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis","volume":"153","author":"Starnbach","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0050","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/IAI.00622-10","article-title":"CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection","volume":"78","author":"Farris","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.06.012_b0060","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jiw244","article-title":"Safety and high level efficacy of the combination malaria vaccine regimen of RTS, S\/AS01B with chimpanzee adenovirus 63 and modified vaccinia Ankara vectored vaccines expressing ME-TRAP","volume":"214","author":"Rampling","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.06.012_b0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mucimm.2024.06.012_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(03)00538-3","article-title":"Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals","volume":"22","author":"Cosma","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.06.012_b0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.mucimm.2024.06.012_b0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.mucimm.2024.06.012_b0085","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.2101076","article-title":"T cell immunogenicity, gene expression profile, and safety of four heterologous prime-boost combinations of HIV vaccine candidates in healthy volunteers: results of the randomized multi-arm phase I\/II ANRS VRI01 trial","volume":"208","author":"Richert","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.mucimm.2024.06.012_b0095","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.vaccine.2021.01.071","article-title":"Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates","volume":"39","author":"Khanna","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.06.012_b0100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.mucimm.2024.06.012_b0105","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/infdis\/jiw485","article-title":"Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection","volume":"214","author":"Russell","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.06.012_b0110","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3389\/fimmu.2018.01981","article-title":"An adaptive Chlamydia trachomatis-specific IFN-gamma-producing CD4+ T cell response is associated with protection against chlamydia reinfection in women","volume":"9","author":"Bakshi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0115","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.179.6.4027","article-title":"Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease","volume":"179","author":"O'Connell","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0120","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1128\/IAI.00169-12","article-title":"The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection","volume":"80","author":"Riley","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0125","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","volume":"80","author":"Goonetilleke","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.06.012_b0135","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2006.11.044","article-title":"Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut","volume":"25","author":"Lin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.06.012_b0140","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.4049\/jimmunol.181.6.4188","article-title":"Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination","volume":"181","author":"Kaufman","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.virol.2007.05.028","article-title":"Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing","volume":"367","author":"Tatsis","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.mucimm.2024.06.012_b0150","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.03850-13","article-title":"Increased mucosal CD4+ T cell activation in rhesus macaques following vaccination with an adenoviral vector","volume":"88","author":"Bukh","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2958.2007.06050.x","article-title":"The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding","volume":"67","author":"Moelleken","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/2049-632X.12213","article-title":"The Chlamydia protease CPAF: caution, precautions and function","volume":"72","author":"Tan","year":"2014","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.mucimm.2024.06.012_b0165","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/infdis\/jiab496","article-title":"Reduced endometrial ascension and enhanced reinfection associated with IgG antibodies to specific Chlamydia trachomatis proteins in women at risk for chlamydia","volume":"225","author":"Liu","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.06.012_b0170","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/IAI.05022-11","article-title":"Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection","volume":"79","author":"Murthy","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0175","first-page":"2638","article-title":"Evaluation of the immunogenicity and protective efficacy of a Chlamydia muridarum protein OmcB and its C segment in BALB\/c mice","volume":"136","author":"Deng","year":"2023","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.mucimm.2024.06.012_b0180","doi-asserted-by":"crossref","first-page":"e10768","DOI":"10.1371\/journal.pone.0010768","article-title":"Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model","volume":"5","author":"Olsen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mucimm.2024.06.012_b0185","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.vaccine.2009.12.064","article-title":"Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge","volume":"28","author":"Chaganty","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.06.012_b0190","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2007.02.010","article-title":"Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection","volume":"25","author":"Cong","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.06.012_b0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cellimm.2006.10.002","article-title":"The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells","volume":"242","author":"Murphey","year":"2006","journal-title":"Cell Immunol."},{"key":"10.1016\/j.mucimm.2024.06.012_b0200","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa8205","article-title":"Vaccines. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2024.06.012_b0205","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2017.07.007","article-title":"Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis","volume":"190","author":"Kou","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.mucimm.2024.06.012_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: an open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mucimm.2024.06.012_b0220","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2015.01.042","article-title":"The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species","volume":"33","author":"Dicks","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.06.012_b0225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.chom.2008.10.005","article-title":"Structural basis for activation and inhibition of the secreted chlamydia protease CPAF","volume":"4","author":"Huang","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mucimm.2024.06.012_b0235","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/iai.56.5.1320-1325.1988","article-title":"Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection","volume":"56","author":"Ramsey","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0240","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00143-18","article-title":"T cell-independent gamma interferon and B cells cooperate to prevent mortality associated with disseminated Chlamydia muridarum genital tract infection","volume":"86","author":"Poston","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0245","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1128\/iai.64.12.4976-4983.1996","article-title":"Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection","volume":"64","author":"Kelly","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.06.012_b0250","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/iai.65.8.3065-3073.1997","article-title":"Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response","volume":"65","author":"Darville","year":"1997","journal-title":"Infect. Immun."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T05:49:01Z","timestamp":1730526541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021924000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1933021924000667"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.06.012","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in na\u00efve mice","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}